Clinical Trial Update: A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic/pharmacodynamic study evaluating interactions between bictegravir, tenofovir alafenamide, and rifapentine in healthy adults has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Bictegravir (bictegravir)
• Tenofovir alafenamide (tenofovir alafenamide)
• rifapentine (rifapentine)

Snippet

Sponsor: Yale University | Conditions: Tuberculosis, Hiv | Phase 4 | Status: WITHDRAWN